Epilepsy is an intractable disease, though many treatment modalities have been developed. Recently, noninvasive transcranial direct current stimulation (tDCS), which can change brain excitability, was introduced and has been applied for therapeutic purposes regarding epilepsy. A suppression of seizures was experienced by cathodal tDCS in a medication refractory pediatric epileptic patient. Th e patient was an 11-year-old female who had focal cortical dysplasia of the cerebral hemisphere. The patient was treated with antiepileptic drugs but the mean seizure frequency was still eight episodes per month. Th e tDCS cathode was placed at the midpoint of P4 and T4 in the 10-20 EEG system where the abnormal wave was observed on a sleep EEG. Two mA of tDCS was applied 20 minutes a day, fi ve days a week for two weeks. During a two-month period after treatment termination, only six seizure attacks occurred, and the duration of each seizure episode also decreased. tDCS was applied under the same conditions for another two weeks. For two months after the second treatment session, only one seizure attack occurred, and it showed great improvement compared to the eight seizure attacks per month before the tDCS treatment. Th e medications were not changed, and there were no notable side eff ects that were caused by tDCS.
INTRODUCTION
Epilepsy is a chronic neurologic disorder that manifests in diverse ways. Th e two hallmarks of seizure generation are hyperexcitability of neurons and hypersynchrony of neural circuits. 1 Treatment of epilepsy is focused on inactivation of the excitative brain cortex, including antiepileptic drugs and surgery. However, epilepsy is intractable in some patients. 2, 3 Recently, noninvasive techniques, such as repetitive transcranial magnetic
www.e-arm.org stimulation (rTMS) and transcranial direct current stimulation (tDCS) that can change brain excitability, were introduced. 4 These techniques have been applied for therapeutic purposes in epilepsy, but there have been no reports on tDCS being applied on epileptic patients in Korea. Suppression of seizure by cathodal tDCS in a medication refractory epileptic patient was observed.
CASE REPORT
An 11-year-old female patient suffering from epileptic seizures visited our clinic. The patient born by was a normal spontaneous vaginal delivery at 39 weeks/3.08 kg, and she was the second child of two siblings. The patient presented her first seizure attack at the age of four. A brain magnetic resonance image revealed cortical dysplasia of both sylvian areas. Th e patient was diagnosed with congenital bilateral perisylvian syndrome (Fig. 1) . Electroencephalography (EEG) revealed diffuse slow waves on the right hemisphere and intermittent spikes on the temporoparietal area ( Fig. 2) . A chromosomal study showed 46, XX, inversion 9. The patient also was diagnosed with mental retardation and microcephaly. The patient presented seizure attacks an average of eight times a month. In spite of prescribing Topamax ® (topiramate, 10 mg/day) and Trilpetal ® (oxycarbazepine, 600 mg/day), the seizure frequency and durations were constant. Cathodal tDCS was applied on the right temporo-parietal area that showed abnormal fi ndings in an EEG. Phoresor www.e-arm.org Lake City, USA) was used as a direct current generator. The electrodes attached to the scalp were 5×5 cm (area 25 cm 2 ) sponge electrodes. The anode was attached on the area above the left orbit and the cathode between P4 and T4 of the international 10-20 system of electrode placement (Fig. 3) . tDCS was performed for 20 minutes using 2 mA, 5 times a week for 2 weeks. Th e patient did not present seizures during the intervention period. For two months after the intervention period, the patient suff ered seizure attacks six times. Th is was half as frequent as before the intervention, which was eight times a month. Th e duration of each seizure was less than 30 seconds after the intervention compared to 30 seconds to 1 minute before the intervention. Two months after the fi rst intervention session, a second intervention session with the same methods was conducted for two weeks. After the second intervention session, the patient had a seizure attack just once over two months.
DISCUSSION
Non-invasive brain stimulation techniques such as rTMS and tDCS have been investigated for suppression of epilepsy. Th ough several studies have suggested rTMS reduces epilepsy, there is little evidence on suppression of epilepsy by tDCS. 4 tDCS causes excitation of excitatory glutamatergic cortical pathways and suppression of intracortical inhibitory pathways. 5 This is based on findings that a surface-positive current enhances neuronal firing and increases the size of evoked potentials while a surfacenegative current has the opposite effect. 6 Liebetanz, et al. 7 reported anticonvulsive effects induced by cathodal tDCS in rats. Generally, antiepileptic drugs (AEDs) and surgery are treatments for epilepsy. The recurrence rates were about 30% after treatment with AEDs and about 30-50% after treatment with surgery. 2, 3 Recently, noninvasive techniques, such as rTMS and tDCS, were introduced as therapeutic options for intractable epilepsy. 4 Fregni et al. showed that nineteen patients (mean age=24) with refractory epilepsy underwent one session of active tDCS (20 minutes, 1 mA). Fregni et al. 8 showed a significant reduction in the number of epileptiform discharges and decrease in seizure frequency compared with sham tDCS, and the effects lasted for one month. The results in this study also showed that treatment for two weeks, five days a week tDCS (20 minutes, 2 mA) reduced epileptic seizures. As several authors have demonstrated in humans, cathodal stimulation decreased cortical excitability. In this study, the fi ndings suggest that cathodal tDCS reduced cortical excitability, thus suppressing epileptic activity. Th is can be evidence of tDCS as a therapeutic option for treatment of seizures. Further studies regarding the correct attachment sites of reference electrodes, tDCS intensity, duration, and frequency are needed. We applied cathode electrode on midpoint between P4 and T4 area and anode electrode on left supraorbital area. The stimulation intensity was 2 mA and the duration was 20 minutes.
